762287-57-0

  • Product Name4-Chloro-2-methoxyphenylboronic acid
  • Molecular FormulaC7H8BClO3
  • Molecular Weight186.4
  • Purity99%
Inquiry

Product Details

Quick Details

  • CasNo: 762287-57-0
  • Molecular Formula: C7H8BClO3
  • Purity: 99%

4-Chloro-2-methoxyphenylboronic acid 762287-57-0 with Best Price and Fast Delivery

  • Molecular Formula:C7H8BClO3
  • Molecular Weight:186.403
  • Melting Point:128-134 °C 
  • Boiling Point:345.436 °C at 760 mmHg 
  • PKA:8.42±0.58(Predicted) 
  • Flash Point:162.714 °C 
  • PSA:49.69000 
  • Density:1.325 g/cm3 
  • LogP:0.02840 

4-Chloro-2-methoxyphenylboronic acid(Cas 762287-57-0) Usage

Description 4-Chloro-2-methoxyphenylboronic acid is a biochemical reagent that can be used as a biomaterial or organic compound for life science related research.

Uses

suzuki reaction. 4-Chloro-2-methoxyphenylboronic acid is a boronic acid derivative with specific substituents on the phenyl ring. Boronic acids are known for their utility in organic synthesis, particularly in reactions like Suzuki-Miyaura cross-coupling reactions.

Canonical SMILES B(C1=C(C=C(C=C1)Cl)OC)(O)O
Exact Mass 186.0255020 g/mol
Monoisotopic Mass 186.0255020 g/mol
Complexity 145

 

762287-57-0 Relevant articles

Identification of Atuveciclib (BAY 1143572), the First Highly Selective, Clinical PTEFb/CDK9 Inhibitor for the Treatment of Cancer

Dr. Ulrich Lücking, Dr. Arne Scholz, Dr. Philip Lienau, Dr. Gerhard Siemeister, Dr. Dirk Kosemund, Dr. Rolf Bohlmann, Dr. Hans Briem, Dr. Ildiko Terebesi, Dr. Kirstin Meyer, Dr. Katja Prelle, Dr. Karsten Denner, Dr. Ulf Bömer, Dr. Martina Schäfer, Dr. Knut Eis, Dr. Ray Valencia, Dr. Stuart Ince, Dr. Franz von Nussbaum, Dr. Dominik Mumberg, Dr. Karl Ziegelbauer, Dr. Bert Klebl, Dr. Axel Choidas, Dr. Peter Nussbaumer, Dr. Matthias Baumann, Dr. Carsten Schultz-Fademrecht, Dr. Gerd Rühter, Dr. Jan Eickhoff, Dr. Michael Brands

ChemMedChem, Volume12, Issue21 November 8, 2017 Pages 1776-1793

1-(3-{[4-(4-Chloro-2-methoxyphenyl)-1,3,5-triazin-2-yl]amino}phenyl)methanesulfonamide (15): A mixture of crude 3-[(4-chloro-1,3,5-triazin-2-yl)amino]benzenemethanesulfonamide (174 mg), 4-chloro-2-methoxyphenylboronic acid (116 mg, 0.62 mmol) and K3PO4 (217 mg, 1.02 mmol) in dioxane/water (10:1, 10 mL) was degassed with a stream of nitrogen for 15 min. Pd(dppf)Cl2⋅CH2Cl2 (28 mg, 0.03 mmol) was added and the reaction mixture was heated for 90 min at 145 °C in a microwave oven. The mixture was diluted with EtOAc and washed with sat. aq. NaHCO3. The organic phase was dried (Na2SO4), filtered and concentrated. The residue was purified by preparative HPLC (acidic conditions) to give 15 as a light beige solid (13 mg, 0.03 mmol): 1H NMR (400 MHz, [D6]DMSO): δ=3.90 (s, 3 H), 4.24 (s, 2 H), 6.86 (br s, 2 H), 7.08 (d, 1 H), 7.15 (d, 1 H), 7.28 (d, 1 H), 7.36 (t, 1 H), 7.74 (s, 1 H), 7.88 (m, 2 H), 8.81 (s, 1 H), 10.44 ppm (s, 1 H); MS (ESI) m/z: 406 [M+H]+.

Discovery of Conformationally Constrained ALK2 Inhibitors

Héctor González-Álvarez, Deeba Ensan, Tao Xin, Jong Fu Wong, Carlos A. Zepeda-Velázquez, Julien Cros, Melissa N. Sweeney, Laurent Hoffer, Taira Kiyota, Brian J. Wilson, Ahmed Aman, Owen Roberts, Methvin B. Isaac, Alex N. Bullock, David Smil*, and Rima Al-awar*

J. Med. Chem. 2024, 67, 6, 4707–4725

An alternative route, illustrated in Scheme 4 and featuring an additional homologation step, was employed for the preparation of M4K2308 (32) and M4K2281 (33). The ring closure approach used for the preparation of 32 and 33 had to be completely reformulated from previous synthetic strategies due to the formation of a styrene when using SNAr reaction conditions. Commercially available 9 and 4-chloro-2-methoxyphenylboronic acid (23) were coupled under Suzuki–Miyaura conditions to afford intermediate 24.

Identification of Atuveciclib (BAY 1143572), the First Highly Selective, Clinical PTEFb/CDK9 Inhibitor for the Treatment of Cancer

K Meyer, K Prelle, K Denner, U Bömer, M Schäfer

ChemMedChem

A mixture of crude 3-[(4-chloro-1,3,5-triazin-2-yl)amino]benzenemethanesulfonamide (174 mg), 4-chloro-2-methoxyphenylboronic acid (116 mg, 0.62 mmol) and K3PO4 (217 mg, 1.02 mmol) in dioxane/water (10:1, 10 mL) was degassed with a stream of nitrogen for 15 min.

762287-57-0 Upstream products

  • 174913-09-8
    174913-09-8

    2-bromo-5-chloroanisole

  • 121-43-7
    121-43-7

    Trimethyl borate

762287-57-0 Downstream products

  • 1173157-19-1
    1173157-19-1

    4-(4-chloro-2-methoxyphenyl)pyridine 1-oxide

  • 959132-85-5
    959132-85-5

    2-[3-(4-chloro-2-methoxyphenyl)-4-(2-fluorobenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-[1-methyl-1-(3-trifluoromethyl-phenyl)ethyl]-acetamide

  • 1238196-66-1
    1238196-66-1

    (4-chloro-2-hydroxyphenyl)boronic acid

  • 1108184-76-4
    1108184-76-4

    C25H25ClN4O2

Relevant Products